Table 1 Clinical features of patients with angiosarcoma included in the cohort.
From: Clinical implications of systemic and local immune responses in human angiosarcoma
Clinical characteristics | n |
|---|---|
Total number of patients | 150 (100%) |
Sex | |
Male | 94 (62.7%) |
Female | 56 (37.3%) |
Age at diagnosis (years) | |
Median (range) | 67 (26–104) |
> 65 | 83 (55.3%) |
≤ 65 | 67 (44.7%) |
Ethnicity | |
Chinese | 124 (82.7%) |
Other | 26 (17.3%) |
Performance status (ECOG score) | |
0 | 70 (49.0%) |
1 | 52 (36.4%) |
2 | 11 (7.7%) |
3 | 6 (4.2%) |
4 | 4 (2.8%) |
Cardiovascular risk factors† | |
Present | 90 (60.0%) |
Absent | 60 (40.0%) |
Primary tumor site | |
Head & neck | 88 (58.7%) |
Scalp | 72 (48%) |
Non-scalp | 16 (10.7%) |
Breast | 13 (8.7%) |
Limb/trunk | 13 (8.7%) |
Other‡ | 36 (24%) |
Etiology | |
Primary | 132 (88.0%) |
Secondary | 18 (12.0%) |
Radiation (n = 8) | |
Chronic lymphedema (n = 3) | |
Thrombosed arteriovenous fistula (n = 3) | |
Organ transplant (n = 1) | |
Neurofibromatosis Type 1 (n = 1) | |
Li-Fraumeni syndrome (n = 1) | |
Xeroderma pigmentosum (n = 1) | |
Epithelioid component | |
Present | 59 (51.3%) |
Absent | 56 (48.7%) |
Distant metastasis at diagnosis | |
Present | 60 (40.0%) |
Absent | 90 (60.0%) |
Curative surgery | 48 (32.0%) |
Other* | 42 (28.0%) |
